Physician liability: The next big thing for personalized medicine?

Gary Marchant, Doug E. Campos-Outcalt, Rachel A. Lindor

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Liability is likely to be a major driver for the future direction and implementation of personalized medicine, spurring the adoption of genetic tests and other pharmacogenomic technologies, in some cases appropriately, and in other cases prematurely or as inefficient defensive medicine. While all entities in the personalized medicine chain will face liability risks, physicians will be at the greatest risk owing to their lack of defenses, limited experience in dealing with genetics and the growing disparities within the profession in implementing new medical technologies. The history of liability for genetic testing, primarily in the prenatal testing context, suggests that liability will often be both unpredictable and influential in changing medical practice. It is critical to anticipate and attempt to prevent such liability risks in a proactive manner so to minimize the disruptive impact that liability can cause.

Original languageEnglish (US)
Pages (from-to)457-467
Number of pages11
JournalPersonalized Medicine
Volume8
Issue number4
DOIs
StatePublished - Jul 2011

Fingerprint

Precision Medicine
Physicians
Defensive Medicine
Technology
Pharmacogenetics
Genetic Testing
History

Keywords

  • BRCA
  • gene-expression profiling
  • genetics
  • lawsuit
  • liability
  • litigation
  • pharmacogenomics
  • physician liability
  • whole-genome sequencing

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Medicine(all)

Cite this

Physician liability : The next big thing for personalized medicine? / Marchant, Gary; Campos-Outcalt, Doug E.; Lindor, Rachel A.

In: Personalized Medicine, Vol. 8, No. 4, 07.2011, p. 457-467.

Research output: Contribution to journalArticle

Marchant, Gary ; Campos-Outcalt, Doug E. ; Lindor, Rachel A. / Physician liability : The next big thing for personalized medicine?. In: Personalized Medicine. 2011 ; Vol. 8, No. 4. pp. 457-467.
@article{d8391f82378648a88ecfc9e480d83c4b,
title = "Physician liability: The next big thing for personalized medicine?",
abstract = "Liability is likely to be a major driver for the future direction and implementation of personalized medicine, spurring the adoption of genetic tests and other pharmacogenomic technologies, in some cases appropriately, and in other cases prematurely or as inefficient defensive medicine. While all entities in the personalized medicine chain will face liability risks, physicians will be at the greatest risk owing to their lack of defenses, limited experience in dealing with genetics and the growing disparities within the profession in implementing new medical technologies. The history of liability for genetic testing, primarily in the prenatal testing context, suggests that liability will often be both unpredictable and influential in changing medical practice. It is critical to anticipate and attempt to prevent such liability risks in a proactive manner so to minimize the disruptive impact that liability can cause.",
keywords = "BRCA, gene-expression profiling, genetics, lawsuit, liability, litigation, pharmacogenomics, physician liability, whole-genome sequencing",
author = "Gary Marchant and Campos-Outcalt, {Doug E.} and Lindor, {Rachel A.}",
year = "2011",
month = "7",
doi = "10.2217/pme.11.33",
language = "English (US)",
volume = "8",
pages = "457--467",
journal = "Personalized Medicine",
issn = "1741-0541",
publisher = "Future Medicine Ltd.",
number = "4",

}

TY - JOUR

T1 - Physician liability

T2 - The next big thing for personalized medicine?

AU - Marchant, Gary

AU - Campos-Outcalt, Doug E.

AU - Lindor, Rachel A.

PY - 2011/7

Y1 - 2011/7

N2 - Liability is likely to be a major driver for the future direction and implementation of personalized medicine, spurring the adoption of genetic tests and other pharmacogenomic technologies, in some cases appropriately, and in other cases prematurely or as inefficient defensive medicine. While all entities in the personalized medicine chain will face liability risks, physicians will be at the greatest risk owing to their lack of defenses, limited experience in dealing with genetics and the growing disparities within the profession in implementing new medical technologies. The history of liability for genetic testing, primarily in the prenatal testing context, suggests that liability will often be both unpredictable and influential in changing medical practice. It is critical to anticipate and attempt to prevent such liability risks in a proactive manner so to minimize the disruptive impact that liability can cause.

AB - Liability is likely to be a major driver for the future direction and implementation of personalized medicine, spurring the adoption of genetic tests and other pharmacogenomic technologies, in some cases appropriately, and in other cases prematurely or as inefficient defensive medicine. While all entities in the personalized medicine chain will face liability risks, physicians will be at the greatest risk owing to their lack of defenses, limited experience in dealing with genetics and the growing disparities within the profession in implementing new medical technologies. The history of liability for genetic testing, primarily in the prenatal testing context, suggests that liability will often be both unpredictable and influential in changing medical practice. It is critical to anticipate and attempt to prevent such liability risks in a proactive manner so to minimize the disruptive impact that liability can cause.

KW - BRCA

KW - gene-expression profiling

KW - genetics

KW - lawsuit

KW - liability

KW - litigation

KW - pharmacogenomics

KW - physician liability

KW - whole-genome sequencing

UR - http://www.scopus.com/inward/record.url?scp=79960954006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960954006&partnerID=8YFLogxK

U2 - 10.2217/pme.11.33

DO - 10.2217/pme.11.33

M3 - Article

AN - SCOPUS:79960954006

VL - 8

SP - 457

EP - 467

JO - Personalized Medicine

JF - Personalized Medicine

SN - 1741-0541

IS - 4

ER -